Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Financial Statements

212 Followers

Keros Therapeutics Financial Overview

Keros Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.126; its P/E ratio is -10.87; Keros Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-1.27. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 37.00K$ 83.00K$ 143.00K$ 8.00K-
Gross Profit$ 37.00K$ 83.00K$ 143.00K$ 8.00K-
EBIT$ -45.26M$ -43.11M-$ -39.44M$ -37.51M
EBITDA$ -44.60M$ -42.50M-$ -38.89M$ -36.96M
Net Income Common Stockholders$ -45.26M$ -43.11M$ -40.24M$ -39.44M$ -75.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 405.90M$ 442.40M$ 331.15M$ 287.90M$ 322.00M
Total Assets$ 455.02M$ 485.82M$ 370.02M$ 326.25M$ 356.28M
Total Debt$ 13.96M$ 14.20M$ 14.44M$ 14.31M$ 13.95M
Net Debt$ -391.94M$ -428.20M$ -316.70M$ -273.58M$ -308.05M
Total Liabilities$ 34.11M$ 31.87M$ 37.81M$ 30.41M$ 30.05M
Stockholders Equity$ 420.92M$ 453.95M$ 332.21M$ 295.84M$ 326.26M
Cash Flow-
Free Cash Flow$ -40.11M$ -45.51M-$ -34.53M$ -31.14M
Operating Cash Flow$ -39.80M$ -44.56M$ -25.46M$ -33.98M$ -30.83M
Investing Cash Flow$ -310.00K$ -946.00K$ -541.00K$ -550.00K$ -311.00K
Financing Cash Flow$ 3.53M$ 156.80M$ 69.25M$ 284.00K$ 1.74M
Currency in USD

Keros Therapeutics Earnings and Revenue History

Keros Therapeutics Debt to Assets

Keros Therapeutics Cash Flow

Keros Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis